SRHR:NYE-SRH REIT Covered Call ETF (USD)

ETF | Others |

Last Closing

USD 54.1037

Change

-0.08 (-0.14)%

Market Cap

USD 0.05B

Volume

5.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

-0.34 (-1.68%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.11 (+0.19%)

USD 32.43B
DTB DTB

-0.36 (-1.82%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

-0.01 (-0.03%)

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC)

-0.81 (-1.44%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 22.73B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 19.79B
AVUV Avantis® U.S. Small Cap Value..

+0.04 (+0.04%)

USD 10.49B
DFUV Dimensional US Marketwide Valu..

+0.02 (+0.05%)

USD 10.15B
DFAT Dimensional U.S. Targeted Valu..

+0.02 (+0.04%)

USD 9.40B

ETFs Containing SRHR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.29% 7% C- 17% F
Dividend Return 2.40% 90% A- 84% B
Total Return -5.89% 8% B- 20% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.05B 51% F 18% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike